A Potential Role of Plant/Macrofungi/Algae-Derived Non-Starch Polysaccharide in Colitis Curing: Review of Possible Mechanisms of Action
Open Access
Abstract
Multiple in vitro and in vivo model investigations have suggested a broad spectrum of potential mechanisms by which plant/macrofungi-derived non-starch polysaccharides may play a role in the treatment of inflammatory bowel disease (IBD). This article reviews the in vivo and in vitro evidence of different plant-derived polysaccharides for IBD therapy. Their underlying mechanisms, particularly the molecular mechanisms associated with protective effects in the treatment and prevention of IDB, have been well summarized, including anti-inflammatory, epithelial barrier repair, and the regulation of intestinal flora. Emerging studies have observed the potent role of probiotics in IBD, particularly its ability to modulate gut microbiota, a well-known key factor for IBD. In summary, plant/macrofungi-derived polysaccharides have the potential to be a promising agent for the adjuvant treatment and prevention of IBD and will contribute to the design of well-designed clinical intervention trials that will ultimately improve the therapy of IBD.Keywords
Funding Information
- National Natural Science Foundation of China (81560676)
- SZU Top Ranking Project (860000210)
- Natural Science Foundations of Hebei Province (C2019407092)
- Hebei Province’s Key Research and Development Program (216Z3201G)
- Foundations of Shenzhen Science and Technology Innovation Committee (JCYJ20170413170320959)
- Medical Science and Technology Research Foundation of Guangdong Province, China (A2020157, A2020272)
This publication has 72 references indexed in Scilit:
- Dynamic properties of the tight junction barrierAnnals of the New York Academy of Sciences, 2012
- Intestinal mucosal barrier function in health and diseaseNature Reviews Immunology, 2009
- The beneficial effect of Rheum tanguticum polysaccharide on protecting against diarrhea, colonic inflammation and ulceration in rats with TNBS-induced colitis: The role of macrophage mannose receptor in inflammation and immune responseInternational Immunopharmacology, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activityApoptosis, 2005
- Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogensFEMS Microbiology Reviews, 2004
- Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugsGut, 2001
- Familial Occurrence of Inflammatory Bowel DiseaseNew England Journal of Medicine, 1991